# A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma

> **NCT00498043** · PHASE2 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 222 (actual)

## Conditions studied

- Lymphoma, B-Cell
- Lymphoma, Large-Cell, Diffuse

## Interventions

- **DRUG:** R-CHOP14 induction regimen
- **DRUG:** R-ACVBP14 induction regimen

## Key facts

- **NCT ID:** NCT00498043
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00498043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00498043, "A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00498043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*